levonorgestrel has been researched along with Herpes Genitalis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, SM; Doncel, GF; Gajer, P; Marzinke, MA; Ravel, J; Schwartz, JL; Thurman, AR; Yousefieh, N | 1 |
Aravantinou, M; Blanchard, J; Derby, N; Fernández-Romero, JA; Gettie, A; Grasperge, B; Kenney, J; Kizima, L; Kumar, N; Levendosky, K; Mizenina, O; Robbiani, M; Roberts, K; Rodriguez, A; Seidor, S; Ugaonkar, SR; Wesenberg, A; Wilk, J; Zhang, S; Zydowsky, TM | 1 |
Boyaka, PN; Cherpes, TL; Hall-Stoodley, L; Kaur, B; Pavelko, SD; Quispe Calla, NE; Trout, W; Vicetti Miguel, RD | 1 |
1 trial(s) available for levonorgestrel and Herpes Genitalis
Article | Year |
---|---|
Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
Topics: Adenine; Adult; Anti-HIV Agents; Antiviral Agents; Contraceptive Agents, Hormonal; Contraceptive Devices, Female; Device Removal; Female; Herpes Genitalis; HIV Infections; Humans; Levonorgestrel; Microbiota; Middle Aged; Mucous Membrane; Organophosphates; Tenofovir; Vagina; Young Adult | 2019 |
2 other study(ies) available for levonorgestrel and Herpes Genitalis
Article | Year |
---|---|
A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
Topics: Administration, Intravaginal; Animals; Antiviral Agents; Carrageenan; Cell Line; Contraceptive Agents, Female; Contraceptive Devices, Female; Drug Delivery Systems; Equipment Design; Female; HeLa Cells; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Reverse Transcriptase; HIV-1; Human papillomavirus 16; Humans; Levonorgestrel; Macaca mulatta; Papillomavirus Infections; Pregnancy; Pyridines; Urea; Zinc Acetate | 2015 |
Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.
Topics: Animals; Contraceptive Agents, Female; Disease Models, Animal; Disease Susceptibility; Estrogens; Female; Herpes Genitalis; Herpesvirus 2, Human; Levonorgestrel; Medroxyprogesterone Acetate; Mice; Mucous Membrane; Permeability; Vagina | 2016 |